Our Science
The SGC is a public-private partnership whose mandate is to promote the development of new medicines by carrying out basic science of relevance to drug discovery and placing all information, reagents and know-how into the public domain without restriction.
The core mandate of the SGC is to determine 3D structures on a large scale and cost-effectively - targeting human proteins of biomedical importance and proteins from human parasites that represent potential drug targets. In these two areas, the SGC is now responsible for >25% and >50% of all structures deposited into the Protein Data Bank each year. Our structural biology insights have allowed us to make significant progress toward the understanding of
